Webinar: SARS-CoV-2 Total Antibody Immunoassay - Launch soon

01. Dec 2021 | 2 min read

Webinar: SARS-CoV-2 Total Antibody Immunoassay - Launch soon

SARS-CoV-2 Total Antibody Immunoassay - Soon on chemical analysers

In the effort to restrain the COVID-19 pandemic, serological testing to detect SARS-CoV-2 specific antibodies will be important in disease and community management.

Gentian has developed a turbidimetric SARS-CoV-2 Total Antibody Immunoassay in collaboration with the University in Tromsø (UiT), Norway, that will be launched soon. This quantitative antibody test captures the full immune response detecting antibodies targeting the S1 subunit with high sensitivity and specificity. It will be calibrated against the international WHO international standard.

 

Webinar: High-throughput SARS-CoV-2 Total Antibody Immunoassay

Learn more about our SARS-CoV-2 total antibody immunoassay that will be launched soon.

 

SARS-CoV-2_9155v01

 

Get in touch for more information about the immunoassay

Let us know if you want more information about the assay or want to validate the assay in your laboratory at the time of launch.

Please send us an email to marketing@gentian.com or fill out the form to the right. Our Product Manager for SARS-CoV-2 Total Antibody Immunoassay will get in touch.

You may also read


COVID-19 and calprotectin's clinical value

Dec 21, 2021

COVID-19 and calprotectin's clinical value

Calprotectin as a valuable prognostic marker in care of COVID-19 patients The rising numbers of SARS-CoV-2..

Webinar: SARS-CoV-2 Total Antibody Immunoassay - Launch soon

Dec 01, 2021

Webinar: SARS-CoV-2 Total Antibody Immunoassay - Launch soon

SARS-CoV-2 Total Antibody Immunoassay - Soon on chemical analysers In the effort to restrain the COVID-19..

Webinar: The biomarker calprotectin - for plasma and serum

Nov 30, 2021

Webinar: The biomarker calprotectin - for plasma and serum

Biomarker for early detection of the inflammatory response to infections Calprotectin is one of the earliest..